China · Delayed Price · Currency is CNY China Resources Boya Bio-pharmaceutical Group Co.,Ltd Company Description
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China.
It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII.
The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine injection.
In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drugs.
The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou, China.
| Country | China |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,947 |
| CEO | Xiaoming Liang |
Contact Details
Address: No. 333, Huiquan Road Fuzhou, 344000 China | |
| Phone | 86 79 4822 4549 |
| Website | china-boya.com |
Stock Details
| Ticker Symbol | 300294 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100001FF1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yuxuan Pan | Chief Financial Officer, Board Secretary and Director |
| Shousun Ii | Vice President |
| Shuanhong Zhang | Vice President |
| Zi He Wang | Accounting Supervisor |
| Qingsong Lin | Vice President |